Under construction – not a live service
Sign in
Taking people in SpainNo phase

Weight Management Program for Adults With Obesity During Cancer Treatment

Tests a diet, home exercise and behavioral support program in adults with obesity and cancer.

Plain-language title generated from the registry record
Registry title: Weight Management in Obese Cancer Patients During Curative Active Treatment

Key facts

Where
L'Hospitalet de Llobregat, SpainSee the site

Where in Spain

  • Institut Català d'Oncologia. Catalan Institute of OncologyL'Hospitalet de Llobregat, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Institut d'Investigació Biomèdica de Bellvitge
Trial code
NCT07058207
Record updated
28 July 2025
Original description
This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.Read full original descriptionShow less

Weight Management in Obese Cancer Patients During Curative Active Treatment (CANOBESE Study): A Feasibility Study

This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.

The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.

Inclusion: Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend; Expected oncological treatment time ≥ 3 months; BMI ≥ 30 kg/m²; Resident in the Barcelona area up to the completion of cancer treatment; ECOG Perfomance Status (PS) 0-1; Availability of internet access.

Exclusion: Surgery as the only treatment; History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery; Patients with any concurrent medical or psychological condition that, in the investigator's opinion, would jeopardize the safety of the patient or compliance with the protocol; Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):; Another active malignancy; Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc; Pre-existing medical condition that precludes adherence to unsupervised exercise, e.g., severe orthopedic conditions, scheduled for a hip or knee replacement, bone metastases, paralysis, dementia, untreated stage 3 hypertension, or unstable angina, heart attack, congestive heart failure or conditions that dictated hospitalization or oxygen within 6-months; Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence); Patients with melanoma and brain tumours; Pregnancy or breastfeeding; Unable to read or understand Spanish or Catalan; Enrolled in a weight loss program; Use of pacemaker or another electrical implanted device.

ClinicalTrials.gov NCT07058207